NEW YORK AND LONDON Celsus Therapeutics (OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announces the appointment of Pablo …
Press Release
Celsus Therapeutics Names Allan Shaw to Board of Directors
NEW YORK AND LONDON Celsus Therapeutics(OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announced today the addition of …
[Read more...] about Celsus Therapeutics Names Allan Shaw to Board of Directors
Celsus Therapeutics MRX-6 Selected as One of the “Top Autoimmune/Anti-Inflammatory Disease Projects to Watch” by Elsevier Business Intelligence
NEW YORK AND LONDON Celsus Therapeutics (OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announced that the Company MRX-6 …
